1. Home
  2. STIM

STIM

Neuronetics Inc.

Logo Neuronetics Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Founded: 2003 Country:
United States
United States
Employees: N/A City: MALVERN
Market Cap: 131.8M IPO Year: 2018
Target Price: $10.00 AVG Volume (30 days): 184.1K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.05 EPS Growth: N/A
52 Week Low/High: $1.03 - $5.07 Next Earning Date: 05-07-2024
Revenue: $71,348,000 Revenue Growth: 9.42%
Revenue Growth (this year): 13.13% Revenue Growth (next year): 12.98%

Share on Social Networks: